A Glimpse into the PBAC December 2023 Meeting O...

By HEOR Staff Writer

January 30, 2024

Introduction The Pharmaceutical Benefits Advisory Committee (PBAC) concluded its December 2023 meeting with several key decisions that will shape the future of pharmaceutical treatments. Belo...
Groundbreaking Medical Innovations in 2023: FDA approvals
Pharmaceutical Pricing and Reimbursement in Latin America
NICE’s Preparations for Evaluating New Alzheimer’s Treatments
The Cost-Effectiveness of Efgartigimod Alfa (Vyvgart) in the Treatment of Mya...
Addressing the Disparity: Treating Childhood Cancer in Low and Middle-Income ...
Pioneering Treatments for Paroxysmal Nocturnal Hemoglobinuria
Navigating the Complexities of Generics and Biosimilars in Portugal
Spinal Muscular Atrophy: A Comprehensive Review of Newborn Screening, Treatme...
Unravelling the Impact of the 340B Program on US Healthcare
Enhancing Access: Cross-Sector Collaboration in Healthcare
Revamping Medical Regulations: A Call for Comprehensive Reform
High-Cost Medicines in Thailand: A Global Perspective and Policy Recommendations